Target intelligence / Profile preview

Meprin A subunit alpha pseudogene 1 (MEP1AP1)

Target
MEP1AP1
Molecular classification
Other (pseudogene)
01

Overview

**Meprin A subunit alpha pseudogene 1 (MEP1AP1) is classified as a pseudogene**, meaning it is a non-functional segment of DNA similar to the working gene for meprin A subunit alpha (MEP1A)[1]. Pseudogenes do not encode functional proteins and are not considered therapeutic targets. There is no evidence that MEP1AP1 is transcribed into a biologically meaningful RNA or protein, nor are there currently known disease associations, biological functions, or drug interactions attributed to it[1][8]. **Key context:** - The *functional* version, meprin A subunit alpha (*MEP1A*), is an active **metallopeptidase** with roles in inflammation and various diseases, but **MEP1AP1 is only a pseudogene** with no known protein product or functional role[1][7]. - MEP1AP1 should not be confused with MEP1A or the related MEP1B, which are genuine protein-coding genes and may be considered targets in some contexts[2][4][7]. **Summary:** "Meprin A subunit alpha pseudogene 1" is a non-functional pseudogene and not a therapeutic target, so most structured fields do not apply or should be left null[1][8].

Other names
meprin A, alpha pseudogene 1
02

Mechanism of action

None

03

Biological functions

None—pseudogene, does not encode a functional protein
04

Disease associations

None—no reported role in disease as a functional molecule

Beyond the preview

Go deeper on Meprin A subunit alpha pseudogene 1 (MEP1AP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Meprin A subunit alpha pseudogene 1 (MEP1AP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call